Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Comments on Alegría and Irarrázaval (2017): Is diacerein an alternative for the treatment of osteoarthritis?

Leeb B.

Medwave. 2018 Apr 12;18(2):e7193. doi: 10.5867/medwave.2018.02.7193. Spanish, English. No abstract available.

PMID:
29677177
2.

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Reginster JL, Arden NK, Haugen IK, Rannou F, Cavalier E, Bruyère O, Branco J, Chapurlat R, Collaud Basset S, Al-Daghri NM, Dennison EM, Herrero-Beaumont G, Laslop A, Leeb BF, Maggi S, Mkinsi O, Povzun AS, Prieto-Alhambra D, Thomas T, Uebelhart D, Veronese N, Cooper C.

Semin Arthritis Rheum. 2018 Aug;48(1):1-8. doi: 10.1016/j.semarthrit.2017.12.003. Epub 2017 Dec 7. Review.

3.

Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, Martel-Pelletier J, Monfort J, Pelletier JP, Rizzoli R, Reginster JY.

Drugs Aging. 2017 May;34(5):413. doi: 10.1007/s40266-017-0457-7. No abstract available.

PMID:
28349413
5.

Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools.

van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, Curiale C, Gómez-Centeno A, Haugeberg G, Leeb B, Puolakka K, Ravelli A, Rintelen B, Sarzi-Puttini P.

RMD Open. 2016 Nov 24;2(2):e000302. eCollection 2016. Review.

6.

RADAI-5 and electronic monitoring tools.

Leeb BF, Brezinschek HP, Rintelen B.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S5-S10. Epub 2016 Oct 18. Review.

7.

Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.

Rintelen B, Zwerina J, Herold M, Singer F, Hitzelhammer J, Halder W, Eichbauer-Sturm G, Puchner R, Stetter M, Leeb BF; BIOREG investigator group.

BMC Musculoskelet Disord. 2016 Oct 3;17(1):412. No abstract available.

8.

Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.

Rintelen B, Zwerina J, Herold M, Singer F, Hitzelhammer J, Halder W, Eichbauer-Sturm G, Puchner R, Stetter M, Leeb BF; BIOREG investigator group.

BMC Musculoskelet Disord. 2016 Aug 22;17(1):358. doi: 10.1186/s12891-016-1207-4. Erratum in: BMC Musculoskelet Disord. 2016 Oct 3;17 (1):412.

9.

Should physicians' consider patient perception for modulating treatment?

Leeb BF.

Rheumatology (Oxford). 2016 Nov;55(11):1919-1920. Epub 2016 Jun 21. No abstract available.

PMID:
27330159
10.

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, Martel-Pelletier J, Monfort J, Pelletier JP, Rizzoli R, Reginster JY.

Drugs Aging. 2016 Feb;33(2):75-85. doi: 10.1007/s40266-016-0347-4. Review. Erratum in: Drugs Aging. 2017 May;34(5):413.

11.

Smoking - Does It Affect Rheumatoid Arthritis Activity? Does It Matter?

Leeb BF, Mai HT.

J Rheumatol. 2015 Jul;42(7):1072-4. doi: 10.3899/jrheum.150491. No abstract available.

PMID:
26136547
12.

Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey.

Puchner R, Brezinschek HP, Fritz J, Herold M, Mustak M, Nothnagl T, Puchner SE, Studnicka-Benke A, Leeb BF.

BMC Musculoskelet Disord. 2015 May 6;16:109. doi: 10.1186/s12891-015-0567-5.

13.

Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA).

Leeb BF, Haindl PM, Brezinschek HP, Mai HT, Deutsch C, Rintelen B.

BMC Musculoskelet Disord. 2015 Apr 1;16:73. doi: 10.1186/s12891-015-0512-7.

14.

RADAI-5 to monitor rheumatoid arthritis.

Leeb BF, Haindl PM, Brezinschek HP, Nothnagl T, Rintelen B.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-55-8. Epub 2014 Oct 30.

PMID:
25365090
15.

Quality of care of rural rheumatoid arthritis patients in Austria.

Puchner R, Brezinschek HP, Herold M, Nothnagl T, Studnicka-Benke A, Fritz J, Leeb BF.

Wien Klin Wochenschr. 2014 Jun;126(11-12):360-7. doi: 10.1007/s00508-014-0540-6. Epub 2014 Mar 28.

PMID:
24676628
16.

[Austrian 3e-recommendations for diagnosis and management of gout 2013].

Sautner J, Gruber J, Herold M, Zwerina J, Leeb BF.

Wien Klin Wochenschr. 2014 Feb;126(3-4):79-89. doi: 10.1007/s00508-013-0469-1. Epub 2013 Dec 3. German.

PMID:
24297266
17.

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewé RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Müller-Ladner U, Ostergaard M, Zochling J, Falzon L, van der Heijde DM.

Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.

18.

Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.

Rintelen B, Sautner J, Haindl P, Mai H, Brezinschek HP, Leeb BF.

J Rheumatol. 2013 Apr;40(4):394-400. doi: 10.3899/jrheum.120952. Epub 2013 Feb 1.

PMID:
23378466
19.

Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis.

Sautner J, Rintelen B, Leeb BF.

Rheumatology (Oxford). 2013 Aug;52(8):1535-7. doi: 10.1093/rheumatology/kes406. Epub 2013 Jan 16. No abstract available.

PMID:
23329684
20.

Rituximab in psoriatic arthritis: an exploratory evaluation.

Jimenez-Boj E, Stamm TA, Sadlonova M, Rovensky J, Raffayová H, Leeb B, Machold KP, Graninger WB, Smolen JS.

Ann Rheum Dis. 2012 Nov;71(11):1868-71. doi: 10.1136/annrheumdis-2012-201897. Epub 2012 Jul 24.

PMID:
22833373
21.

Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.

Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, Hazlewood G, Marks JL, Radner H, Ramiro S, Richards BL, Tarner IH, Aletaha D, Bombardier C, Landewé RB, Müller-Ladner U, Bijlsma JW, Branco JC, Bykerk VP, da Rocha Castelar Pinheiro G, Catrina AI, Hannonen P, Kiely P, Leeb B, Lie E, Martinez-Osuna P, Montecucco C, Ostergaard M, Westhovens R, Zochling J, van der Heijde D.

Rheumatology (Oxford). 2012 Aug;51(8):1416-25. doi: 10.1093/rheumatology/kes032. Epub 2012 Mar 24.

22.

Occupational risk factors for osteoarthritis of the knee: a meta-analysis.

McWilliams DF, Leeb BF, Muthuri SG, Doherty M, Zhang W.

Osteoarthritis Cartilage. 2011 Jul;19(7):829-39. doi: 10.1016/j.joca.2011.02.016. Epub 2011 Mar 5. Review.

23.

Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative.

Hazlewood G, Aletaha D, Carmona L, Landewé RB, van der Heijde DM, Bijlsma JW, Bykerk VP, Canhão H, Catrina AI, Durez P, Edwards CJ, Leeb BF, Mjaavatten MD, Martinez-Osuna P, Montecucco C, Ostergaard M, Serra-Bonett N, Xavier RM, Zochling J, Machado P, Thevissen K, Vercoutere W, Bombardier C.

J Rheumatol Suppl. 2011 Mar;87:54-8. doi: 10.3899/jrheum.101076. Review.

PMID:
21364058
24.

EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Bardin T.

Ann Rheum Dis. 2011 Apr;70(4):571-5. doi: 10.1136/ard.2010.139360. Epub 2011 Jan 20.

PMID:
21257614
25.

European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Pascual E.

Ann Rheum Dis. 2011 Apr;70(4):563-70. doi: 10.1136/ard.2010.139105. Epub 2011 Jan 7.

PMID:
21216817
26.

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M, Silva-Fernández L, Thevissen K, Vercoutere W, Villeneuve E, Aletaha D, Carmona L, Landewé R, van der Heijde D, Bijlsma JW, Bykerk V, Canhão H, Catrina AI, Durez P, Edwards CJ, Mjaavatten MD, Leeb BF, Losada B, Martín-Mola EM, Martinez-Osuna P, Montecucco C, Müller-Ladner U, Østergaard M, Sheane B, Xavier RM, Zochling J, Bombardier C.

Ann Rheum Dis. 2011 Jan;70(1):15-24. doi: 10.1136/ard.2010.130625. Epub 2010 Aug 19.

27.

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.

Gossec L, Bijlsma JW, Bombardier C, Canhão H, Devlin J, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Ostergaard M, Pereira IA, Ramos-Remus C, Zochling J, Dougados M.

Ann Rheum Dis. 2011 Feb;70(2):388-9. doi: 10.1136/ard.2010.128652. Epub 2010 May 14. No abstract available.

PMID:
20472594
28.

International position paper on febuxostat.

Jansen TL, Richette P, Perez-Ruiz F, Tausche AK, Guerne PA, Punzi L, Leeb B, Barskova V, Uhlig T, Pimentão J, Zimmermann-Górska I, Pascual E, Bardin T, Doherty M.

Clin Rheumatol. 2010 Aug;29(8):835-40. doi: 10.1007/s10067-010-1457-8. Epub 2010 Apr 17. Review.

PMID:
20401506
29.
30.

The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.

Leeb BF, Böttcher E, Brezinschek HP, Czerwenka C, Herold M, Hitzelhammer H, Mayrhofer F, Puchner R, Rainer F, Rintelen B, Schirmer M, Stuby U, Bröll H.

Clin Rheumatol. 2010 Feb;29(2):167-74. doi: 10.1007/s10067-009-1304-y. Epub 2009 Nov 11.

31.

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, Herrero-Beaumont G, Kirschner S, Leeb BF, Lohmander LS, Mazières B, Pavelka K, Punzi L, So AK, Tuncer T, Watt I, Bijlsma JW.

Ann Rheum Dis. 2010 Mar;69(3):483-9. doi: 10.1136/ard.2009.113100. Epub 2009 Sep 17. Review.

PMID:
19762361
32.

Comparison of three rheumatoid arthritis disease activity scores in clinical routine.

Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF.

Scand J Rheumatol. 2009;38(5):336-41. doi: 10.1080/03009740902932835.

PMID:
19585379
33.

A comparison of patient questionnaires and composite indexes in routine care of rheumatoid arthritis patients.

Leeb BF, Sautner J, Mai HT, Haindl PM, Deutsch C, Rintelen B.

Joint Bone Spine. 2009 Dec;76(6):658-64. doi: 10.1016/j.jbspin.2009.04.001.

PMID:
19520595
34.

The rheumatoid arthritis disease activity index-5 in daily use. Proposal for disease activity categories.

Rintelen B, Haindl PM, Sautner J, Leeb BA, Deutsch C, Leeb BF.

J Rheumatol. 2009 May;36(5):918-24. doi: 10.3899/jrheum.080863. Epub 2009 Mar 30.

PMID:
19332635
35.

Hotel-based rheumatology, and more.

Leeb BF.

J Rheumatol. 2009 Feb;36(2):455-6; author reply 456-7. doi: 10.3899/jrheum.080818. No abstract available.

PMID:
19208582
36.

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M.

Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.

37.

SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender.

Rintelen B, Haindl PM, Maktari A, Nothnagl T, Hartl E, Leeb BF.

Scand J Rheumatol. 2008 Nov-Dec;37(6):410-3. doi: 10.1080/03009740802241717.

PMID:
18759162
38.

A tool for the assessment of hand involvement in rheumatic disorders in daily routine--the SF-SACRAH (short form score for the assessment and quantification of chronic rheumatic affections of the hands).

Rintelen B, Haindl PM, Mai HT, Sautner J, Maktari A, Leeb BF.

Osteoarthritis Cartilage. 2009 Jan;17(1):59-63. doi: 10.1016/j.joca.2008.05.003. Epub 2008 Jun 16.

39.

[Austrian expert opinion on the standard for expert assessment of course of illness in patients with chronic polyarthritis (rheumatoid arthritis)].

Machold KP, Brezinsek HP, Leeb BF, Pflugbeil S, Rainer F, Singer F, Skoumal M, Stamm TA, Herold M.

Wien Klin Wochenschr. 2008;120(7-8):234-41. doi: 10.1007/s00508-008-0958-9. German. No abstract available.

PMID:
18500599
40.

Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI.

Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B.

J Rheumatol. 2008 Jul;35(7):1294-9. Epub 2008 May 15.

PMID:
18484698
41.

Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.

Brezinschek HP, Hofstaetter T, Leeb BF, Haindl P, Graninger WB.

Curr Opin Rheumatol. 2008 May;20(3):295-9. doi: 10.1097/BOR.0b013e3282ffdeca. Review.

PMID:
18388521
42.

On "Effectiveness of nonpharmacological and nonsurgical interventions..." Moe et al. Phys Ther. 2008;88: 1716-1727.

Leeb BF, Rintelen B.

Phys Ther. 2008 Mar;88(3):407-8; author reply 408. doi: 10.2522/ptj.2008.88.3.407. No abstract available.

PMID:
18310085
43.

EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT.

Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Kaklamanis P, Kloppenburg M, Lohmander LS, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Smolen J, Verbruggen G, Watt I, Zimmermann-Gorska I; ESCISIT.

Ann Rheum Dis. 2009 Jan;68(1):8-17. doi: 10.1136/ard.2007.084772. Epub 2008 Feb 4. Review.

PMID:
18250111
44.

Disease activity score-28 values differ considerably depending on patient's pain perception and sex.

Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B.

J Rheumatol. 2007 Dec;34(12):2382-7. Epub 2007 Nov 1.

PMID:
17985407
45.

[European League Against Rheumatism evidence-based recommendations for diagnosis and management of gout].

Grusch B, Rintelen B, Leeb BF.

Z Rheumatol. 2007 Nov;66(7):568-72. German.

PMID:
17891407
46.

The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.

Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA.

Arthritis Rheum. 2007 Jun 15;57(5):810-5.

47.

Lack of agreement between patients' and physicians' perspectives of rheumatoid arthritis disease activity changes.

Leeb BF, Sautner J, Leeb BA, Fassl C, Rintelen B.

Scand J Rheumatol. 2006 Nov-Dec;35(6):441-6.

PMID:
17343251
48.

The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients.

Leeb BF, Andel I, Sautner J, Fassl C, Nothnagl T, Rintelen B.

Arthritis Rheum. 2007 Mar 15;57(2):256-60.

49.

Should physicians manipulate their assessment tools? No, they shouldn't!

Leeb BF.

J Rheumatol. 2006 Nov;33(11):2359-60; author reply 2360-1. No abstract available.

PMID:
17086615
50.

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dinçer F, Dziedzic K, Häuselmann HJ, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Maheu E, Martín-Mola E, Pavelka K, Punzi L, Reiter S, Sautner J, Smolen J, Verbruggen G, Zimmermann-Górska I.

Ann Rheum Dis. 2007 Mar;66(3):377-88. Epub 2006 Oct 17.

Supplemental Content

Support Center